chr17-10521326-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_017534.6(MYH2):​c.5780G>A​(p.Arg1927Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00626 in 1,614,124 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0064 ( 46 hom. )

Consequence

MYH2
NM_017534.6 missense

Scores

7
6
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.91
Variant links:
Genes affected
MYH2 (HGNC:7572): (myosin heavy chain 2) Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in inclusion body myopathy-3. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, Dann, Eigen, FATHMM_MKL, MutationAssessor, phyloP100way_vertebrate [when AlphaMissense, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.011096537).
BP6
Variant 17-10521326-C-T is Benign according to our data. Variant chr17-10521326-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 197420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00446 (679/152282) while in subpopulation NFE AF= 0.00651 (443/68022). AF 95% confidence interval is 0.00601. There are 6 homozygotes in gnomad4. There are 300 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYH2NM_017534.6 linkc.5780G>A p.Arg1927Gln missense_variant 40/40 ENST00000245503.10 NP_060004.3 Q9UKX2-1
MYH2NM_001100112.2 linkc.5780G>A p.Arg1927Gln missense_variant 40/40 NP_001093582.1 Q9UKX2-1
MYHASNR_125367.1 linkn.168-46211C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYH2ENST00000245503.10 linkc.5780G>A p.Arg1927Gln missense_variant 40/401 NM_017534.6 ENSP00000245503.5 Q9UKX2-1

Frequencies

GnomAD3 genomes
AF:
0.00446
AC:
679
AN:
152164
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.0471
Gnomad AMR
AF:
0.00530
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00330
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00651
Gnomad OTH
AF:
0.00525
GnomAD3 exomes
AF:
0.00410
AC:
1031
AN:
251444
Hom.:
7
AF XY:
0.00445
AC XY:
605
AN XY:
135886
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00243
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00307
Gnomad FIN exome
AF:
0.00236
Gnomad NFE exome
AF:
0.00653
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00644
AC:
9421
AN:
1461842
Hom.:
46
Cov.:
31
AF XY:
0.00629
AC XY:
4574
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.000956
Gnomad4 AMR exome
AF:
0.00293
Gnomad4 ASJ exome
AF:
0.000880
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00333
Gnomad4 FIN exome
AF:
0.00303
Gnomad4 NFE exome
AF:
0.00757
Gnomad4 OTH exome
AF:
0.00596
GnomAD4 genome
AF:
0.00446
AC:
679
AN:
152282
Hom.:
6
Cov.:
32
AF XY:
0.00403
AC XY:
300
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00120
Gnomad4 AMR
AF:
0.00530
Gnomad4 ASJ
AF:
0.000864
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00269
Gnomad4 FIN
AF:
0.00330
Gnomad4 NFE
AF:
0.00651
Gnomad4 OTH
AF:
0.00520
Alfa
AF:
0.00600
Hom.:
1
Bravo
AF:
0.00466
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00744
AC:
64
ExAC
AF:
0.00415
AC:
504
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.00687
EpiControl
AF:
0.00735

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 07, 2016- -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 23, 2020This variant is associated with the following publications: (PMID: 15741996) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024MYH2: BS2 -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 07, 2020- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 15, 2014- -
MYH2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 09, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Myopathy, proximal, and ophthalmoplegia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.50
.;D;D;.
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
.;.;D;D
MetaRNN
Benign
0.011
T;T;T;T
MetaSVM
Uncertain
0.69
D
MutationAssessor
Pathogenic
4.3
.;H;H;.
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.50
N;D;D;.
REVEL
Uncertain
0.51
Sift
Pathogenic
0.0
D;D;D;.
Sift4G
Benign
1.0
T;D;D;T
Polyphen
1.0
.;D;D;.
Vest4
0.81
MVP
0.98
MPC
1.0
ClinPred
0.15
T
GERP RS
5.5
Varity_R
0.37
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34161789; hg19: chr17-10424643; COSMIC: COSV55450500; COSMIC: COSV55450500; API